Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;37(5):460-467.
doi: 10.1002/jca.22003. Epub 2022 Aug 20.

Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?

Susan Louw  1 , Barry Frank Jacobson  1 , Elizabeth Sarah Mayne  2
Affiliations

Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection: Can scoring systems assist?

Susan Louw et al. J Clin Apher. 2022 Oct.

Abstract

Background: Patients with Human Immunodeficiency Virus (HIV) infection are at risk of thrombotic microangiopathies (TMAs) notably thrombotic thrombocytopenic purpura (TTP) and disseminated intravascular coagulation (DIC). Overlap between laboratory results exists resulting in diagnostic ambiguity.

Methods: Routine laboratory results of 71 patients with HIV-associated TTP (HIV-TTP) and 81 with DIC with concomitant HIV infection (HIV-DIC) admitted between 2015 and 2021 to academic hospitals in Johannesburg, South Africa were retrospectively reviewed. Both the PLASMIC and the International Society of Thrombosis and Haemostasis (ISTH) DIC scores were calculated.

Results: Patients with HIV-TTP had significantly (P < .001) increased schistocytes and features of hemolysis including elevated lactate dehydrogenase (LDH)/upper-limit-of-normal ratio (median of 9 (interquartile range [IQR] 5-12) vs 3 (IQR 2-5)) but unexpectedly lower fibrinogen (median 2.8 (IQR 2.2-3.4) vs 4 g/L (IQR 2.5-9.2)) and higher D-dimer (median 4.8 (IQR 2.4-8.1) vs 3.6 g/L (IQR 1.7-6.2)) levels vs the HIV-DIC cohort. Patients with HIV-DIC were more immunocompromised with frequent secondary infections, higher platelet and hemoglobin levels, more deranged coagulation parameters and less hemolysis. Overlap in scoring systems was however observed.

Conclusion: The laboratory parameter overlap between HIV-DIC and HIV-TTP might reflect a shared pathogenesis including endothelial dysfunction and inflammation and further research is required. Fibrinogen in DIC may be elevated as an acute phase reactant and D-dimers may reflect the extensive hemostatic activation in HIV-TTP. Inclusion of additional parameters in TMA scoring systems such the LDH/upper-limit-of-normal ratio, schistocytes count and wider access to ADAMTS-13 testing may enhance diagnostic accuracy and ensure appropriate utilization of plasma.

Keywords: diagnostic scoring systems; disseminated intravascular coagulation (DIC); thrombotic thrombocytopenic purpura (TTP); treatment decisions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest pertaining to the study.

References

    1. Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836‐2846. - PubMed
    1. Appel GB. Thrombotic microangiopathies: similar presentations, different therapies. Cleve Clin J Med. 2017;84(2):114‐130. - PubMed
    1. Bittencourt CE, Ha JP, Maitta RW. Re‐examination of 30‐day survival and relapse rates in patients with thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome. PLoS One. 2015;10(5):e0127744. - PMC - PubMed
    1. Rock G, Clark W, Foley R, et al. TTP: one of the TMA's‐how to sort it out. Transfus Apher Sci. 2017;56(1):57‐58. - PubMed
    1. UNAIDS . Data 2020. https://www.unaids.org/en/resources/documents/2020/unaids-data.

MeSH terms